Ami Fadia
Stock Analyst at Needham
(4.62)
# 223
Out of 5,103 analysts
408
Total ratings
54.86%
Success rate
28.39%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $42.11 | - | 24 | Dec 8, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $304 → $315 | $268.80 | +17.19% | 16 | Dec 8, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $42 | $40.51 | +3.68% | 39 | Nov 24, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $16 | $8.36 | +91.39% | 22 | Nov 24, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $66 → $72 | $78.92 | -8.77% | 27 | Nov 6, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $28 → $29 | $27.15 | +6.81% | 12 | Nov 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $154 | $148.17 | +3.93% | 17 | Nov 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $152.80 | +20.42% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $28.50 | +54.39% | 4 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Buy | $6 → $8 | $2.09 | +282.78% | 10 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.36 | - | 37 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $13.04 | +45.76% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.29 | +179.72% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $12.55 | +123.11% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.08 | +80.92% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $96 | $96.93 | -0.96% | 31 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $174.10 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $167.50 | +20.60% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $26.51 | +32.03% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.45 | +289.26% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $14.36 | +2,128.41% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $26.29 | +185.28% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.45 | +4,900.00% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $13.14 | +379.45% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $29.79 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.37 | +1,505.84% | 4 | Jan 3, 2018 |
Cogent Biosciences
Dec 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $42.11
Upside: -
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $304 → $315
Current: $268.80
Upside: +17.19%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $42
Current: $40.51
Upside: +3.68%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $16
Current: $8.36
Upside: +91.39%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $66 → $72
Current: $78.92
Upside: -8.77%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Buy
Price Target: $28 → $29
Current: $27.15
Upside: +6.81%
Axsome Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $154
Current: $148.17
Upside: +3.93%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $152.80
Upside: +20.42%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $28.50
Upside: +54.39%
Neumora Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.09
Upside: +282.78%
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $21.36
Upside: -
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $13.04
Upside: +45.76%
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $4.29
Upside: +179.72%
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.55
Upside: +123.11%
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.08
Upside: +80.92%
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $96.93
Upside: -0.96%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $174.10
Upside: -
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $167.50
Upside: +20.60%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $26.51
Upside: +32.03%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.45
Upside: +289.26%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $14.36
Upside: +2,128.41%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $26.29
Upside: +185.28%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.45
Upside: +4,900.00%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $13.14
Upside: +379.45%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $29.79
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.37
Upside: +1,505.84%